Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake from plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin resistance. The normal plasma concentration of Apo CIII is 8-15 mg per 100 ml.
序列
人血漿載脂蛋白CIII蛋白產品,又稱Apolipoprotein CIII, apolipoprotein, apolipoproteins.人血漿載脂蛋白CIII產品又稱Apo CIII, ApoCIII, Apo C-III, Apo C3, ApoC3等.